10 Peptide Doctors, Researchers, and Educators to Know in 2026

The peptide conversation is loud. It spans podcasts with millions of listeners, YouTube channels that translate complex science into everyday language, peer-reviewed journals, clinical practices, and Reddit threads where people compare protocols at midnight. Navigating all of it requires knowing who the key voices are and what each one actually represents.

This article is not a ranking. It is not a medical endorsement. It does not declare anyone the "best" doctor in any category. What it is, instead, is a guide to public figures who are actively shaping the peptide conversation in 2026 — physicians, researchers, and educators who are worth knowing about, along with honest context about what each is known for.

None of the people listed here should be treated as a substitute for your own qualified healthcare professional. They are public voices in an evolving conversation.

• The peptide conversation is spread across medicine, research, fitness, biohacking, and longevity — and different voices occupy different parts of that landscape.
• Understanding what a person's background and incentives are helps you evaluate what they say.
• Public educators play a valuable role in translating science — but translation is not the same as clinical guidance.
• Working with a local, qualified practitioner who knows your personal health history is always more valuable than following any public figure's protocol.

Known for: Hosting the Huberman Lab podcast, where he translates neuroscience, physiology, and health research for a general audience.

Dr. Huberman is a neuroscientist and tenured professor at Stanford School of Medicine. His podcast episode on peptides — featuring Dr. Abud Bakri — brought peptide science to one of the largest health audiences in the world. His role in the peptide conversation is primarily that of a scientific communicator and interviewer: he raises the quality of the questions being asked and connects listeners to practitioner perspectives.

It is worth noting that Huberman is not a peptide clinician. He does not prescribe. His value is in the depth and rigor of the discussions he facilitates.

Known for: A featured discussion on the Huberman Lab podcast covering peptide science, uses, and safety in clinical practice.

Dr. Bakri represents the practitioner voice in the peptide conversation — a physician who works with patients in a clinical context and brings real-world perspective to what is being studied and how compounds are being used. The Huberman Lab episode is one of the most widely referenced resources in the peptide education space and is worth engaging with critically — understanding both what it clarifies and where additional context is needed.

Known for: A Diary of a CEO episode on peptides that reached an enormous global audience and brought peptide discussions to people who had never encountered the topic before.

Dr. Tatem's appearance in one of the most-watched health podcast episodes of recent years made him one of the most-searched names in the peptide space. His clinical perspective covers a range of peptide applications and longevity medicine topics. As with any podcast appearance, listeners should engage with the content critically and understand that a podcast episode is not a clinical consultation.

Known for: The "Carnivore MD" approach to health and a YouTube discussion of peptides that presents both use cases and reasons for caution.

Dr. Saladino occupies an interesting position in the peptide conversation: he is associated with an ancestral health framework and has published commentary that both acknowledges potential uses for peptides and raises legitimate reasons to reconsider them. His perspective is useful precisely because it is not uniformly bullish on peptides — he introduces the kind of friction that helps listeners think more carefully.

Understanding his framework and where it comes from helps evaluate which of his points are broadly applicable and which are specific to his philosophical position.

Known for: His practice in longevity medicine, the book Outlive, and a data-driven approach to healthspan and lifespan.

Dr. Attia has discussed GLP-1 medications, hormone optimization, and a range of compounds relevant to the longevity conversation. His approach is highly evidence-oriented, and he is known for being willing to update his views as evidence develops. His work sits at the intersection of preventive medicine and performance — which is the same territory where many peptide discussions live.

He has also been honest about the limits of current evidence, which is a quality worth seeking in anyone you follow in this space.

Known for: Clinical work in peptide therapy and writing that aims to provide practitioners with frameworks for peptide-based protocols.

Dr. Seeds has been one of the more prominent clinical voices specifically within peptide medicine, speaking at conferences and publishing material aimed at practitioners who want to understand how compounds can be incorporated into clinical practice. His work is referenced across the peptide practitioner community. As with any specialized practitioner, his perspective reflects specific clinical experience that may or may not translate uniformly to all patients or populations.

Known for: Regenerative medicine practice, public education on longevity, hormonal health, and peptide-adjacent therapies.

Dr. Killen has been an active public voice in functional and regenerative medicine, discussing compounds studied for tissue repair, skin health, and sexual function. Her work intersects with the peptide conversation particularly in the areas of recovery and regeneration. She represents the growing cohort of practitioners who take peptides seriously as a legitimate clinical topic rather than a fringe interest.

Known for: Extensive self-experimentation with performance and longevity compounds, podcast discussions of peptide protocols, and a vast audience in the biohacking community.

Ben Greenfield is not a physician, but his influence on how the biohacking community thinks about peptides is significant. He has discussed a wide range of compounds in considerable detail and has introduced many people to the category. His perspective is that of an enthusiastic self-experimenter and educator — which means his content can be informative while also requiring critical engagement about the evidence underpinning specific claims.

Understanding the difference between what someone has personally experienced and what clinical evidence supports is important when following any biohacker's content.

Known for: A functional medicine practice focused on performance, energy, and optimization, with active public commentary on peptide therapy.

Dr. Koniver is among the practitioners who have publicly built their clinical identity around peptide-informed medicine. He speaks and writes about compounds in performance and recovery contexts and represents a generation of clinicians who have incorporated peptide protocols into practice ahead of full regulatory frameworks. His public content offers insight into how peptides are being used clinically — with the caveat that clinical practice is not always aligned with peer-reviewed evidence.

Known for: Building the actual evidence base that all public discussion depends on.

Any list of important voices in the peptide space would be incomplete without acknowledging that the most important work is being done by researchers who rarely appear on podcasts. The 2024 review published in Signal Transduction and Targeted Therapy — authored by pharmaceutical scientists studying peptide drug development — represents the kind of evidence-grounded work that should underpin any serious engagement with the peptide category.

The people studying peptide absorption, bioavailability, receptor specificity, and clinical outcomes in controlled trials are the ones whose work will ultimately determine which compounds become medicines and which remain experimental.

Following any of the people above does not replace a conversation with a physician who knows your personal health history. Public figures — even qualified ones — are speaking to general audiences and cannot account for your individual biochemistry, health history, medications, or risk factors.

The most valuable use of public peptide education is building enough literacy to have a more productive conversation with your own practitioner. Visit the Peptides Pro Global blog for compound-specific and safety-focused articles that can help you arrive at that conversation better prepared. The Consultation page is available if you want to take the next step with guidance tailored to your situation.

Are these people endorsing Peptides Pro Global? No. None of the individuals listed in this article are affiliated with or endorsing Peptides Pro Global. They are public figures referenced here for educational context only.

Should I follow one of these people's protocols? Not without adapting it to your individual circumstances with the help of your own practitioner. Protocols designed for a podcast audience are general. Your health situation is specific.

How do I evaluate a public voice in the peptide space? Look at their credentials, what incentives they have, how they handle uncertainty, whether they cite evidence, and whether they acknowledge limitations. Someone who only ever says positive things about peptides is worth approaching skeptically.

Is there peer-reviewed research I can read directly? Yes. The Nature/Signal Transduction review linked in the references is a good starting point. PubMed searches for specific compounds will surface primary literature, though interpreting it well requires some background.

Where can I find more educational content from Peptides Pro Global? The Peptides Pro Global blog and FAQ are your best starting points.

• Huberman Lab: Peptides — The Science, Uses & Safety (with Dr. Abud Bakri) — https://www.youtube.com/watch?v=_DfqnpSbMfE
• Diary of a CEO: Peptide Expert / Dr. Alex Tatem — https://www.youtube.com/watch?v=jt5hHb6kzYM
• Paul Saladino: Peptides Explained — https://www.youtube.com/watch?v=LsfLAI6qBzY
• AMA: What Doctors Want Patients to Know About Injectable Peptides — https://www.ama-assn.org/public-health/prevention-wellness/what-doctors-want-patients-know-about-injectable-peptides
• Nature / Signal Transduction and Targeted Therapy: Advances in Peptide-Based Drug Development — https://www.nature.com/articles/s41392-024-02107-5

Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. References to any individual are for informational and educational context only and do not constitute endorsement. Peptides, injectable compounds, prescription medications, and health products may carry risks and may be regulated differently depending on your country. Always speak with a qualified healthcare professional before using peptides or making health-related decisions.